317 related articles for article (PubMed ID: 21711351)
1. High tryptophan diet reduces extracellular dopamine release via kynurenic acid production in rat striatum.
Okuno A; Fukuwatari T; Shibata K
J Neurochem; 2011 Sep; 118(5):796-805. PubMed ID: 21711351
[TBL] [Abstract][Full Text] [Related]
2. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
4. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
7. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on kynurenic acid production in the rat striatum by tryptophan enantiomers: an in vivo microdialysis study.
Ishii K; Iizuka H; Ogaya T; Song Z; Fukushima T
Chirality; 2011; 23 Suppl 1():E12-5. PubMed ID: 21433090
[TBL] [Abstract][Full Text] [Related]
9. Endogenous kynurenic acid regulates extracellular GABA levels in the rat prefrontal cortex.
Beggiato S; Tanganelli S; Fuxe K; Antonelli T; Schwarcz R; Ferraro L
Neuropharmacology; 2014 Jul; 82():11-8. PubMed ID: 24607890
[TBL] [Abstract][Full Text] [Related]
10. Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum.
Rassoulpour A; Wu HQ; Ferre S; Schwarcz R
J Neurochem; 2005 May; 93(3):762-5. PubMed ID: 15836634
[TBL] [Abstract][Full Text] [Related]
11. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
[TBL] [Abstract][Full Text] [Related]
12. Alteration of kynurenic acid concentration in rat plasma following optically pure kynurenine administration: a comparative study between enantiomers.
Fukushima T; Sone Y; Mitsuhashi S; Tomiya M; Toyo'oka T
Chirality; 2009 Apr; 21(4):468-72. PubMed ID: 18655158
[TBL] [Abstract][Full Text] [Related]
13. On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress.
Lugo-Huitrón R; Blanco-Ayala T; Ugalde-Muñiz P; Carrillo-Mora P; Pedraza-Chaverrí J; Silva-Adaya D; Maldonado PD; Torres I; Pinzón E; Ortiz-Islas E; López T; García E; Pineda B; Torres-Ramos M; Santamaría A; La Cruz VP
Neurotoxicol Teratol; 2011; 33(5):538-47. PubMed ID: 21763768
[TBL] [Abstract][Full Text] [Related]
14. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T
Brain Res Bull; 2005 Oct; 67(3):176-81. PubMed ID: 16144652
[TBL] [Abstract][Full Text] [Related]
15. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
[TBL] [Abstract][Full Text] [Related]
16. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
[TBL] [Abstract][Full Text] [Related]
17. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
18. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
Lopes C; Pereira EF; Wu HQ; Purushottamachar P; Njar V; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2007 Jul; 322(1):48-58. PubMed ID: 17446300
[TBL] [Abstract][Full Text] [Related]
19. Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus.
Moroni F; Cozzi A; Carpendo R; Cipriani G; Veneroni O; Izzo E
Neuropharmacology; 2005 May; 48(6):788-95. PubMed ID: 15829251
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
Amori L; Wu HQ; Marinozzi M; Pellicciari R; Guidetti P; Schwarcz R
Neuroscience; 2009 Mar; 159(1):196-203. PubMed ID: 19138730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]